Lean and Purple Drank: What Is It and How Common Is It in the UK?

Lean—also known as purple drank, dirty Sprite, sizzurp or simply syrup—is a drink usually associated with American hip-hop culture. Images of brightly coloured liquid in polystyrene cups have helped turn it into a recognisable cultural symbol, particularly on social media.

Behind the branding, however, lean is essentially a form of opioid use.

What is lean?

The traditional American version is made by mixing cough syrup containing codeine and promethazine with a fizzy drink. Sweets are sometimes added for flavour and colour.

Codeine is an opioid. It can produce relaxation, warmth, mild euphoria and emotional detachment. Promethazine is a sedating antihistamine that adds to the drowsiness. Together, they can cause a slowed, dreamlike state—which is where the name “lean” is said to come from, as heavily affected users may struggle to stand upright.

The effects can include:

• relaxation and drowsiness;

• mild euphoria;

• slowed thinking and reactions;

• poor coordination;

• nausea and constipation;

• confusion or loss of consciousness;

• dangerously slowed breathing.

• 
  

Lean is not a single, standardised product. Different mixtures may contain different medicines, strengths or additional drugs. A purple colour or professionally printed bottle does not provide any reliable information about what is inside. FRANK warns that drinks sold as lean may contain codeine and promethazine, but may also contain other opioids or substances.

Is lean common in the UK?

The honest answer is that we do not know exactly.

UK drug surveys and treatment statistics do not generally record lean as a separate drug category. Someone seeking treatment may be recorded as using codeine, prescription medicines or opioids rather than “purple drank”. National statistics therefore cannot tell us what percentage of young people or adults use lean specifically.

This means claims that lean is either widespread or virtually nonexistent should be treated cautiously.

The available evidence suggests that it is established but relatively niche in the UK. It appears to be most visible among some adolescents and young adults influenced by rap music, fashion and online drug culture. Its visibility on social media may be considerably greater than the number of people using it regularly.

The Medicines and Healthcare products Regulatory Agency has nevertheless identified a genuine concern. In 2024, the MHRA announced that codeine linctus would become available only on prescription because of evidence of abuse, dependence and overdose. The agency specifically reported that “purple drank” had been promoted through social media to young adults and that sales of codeine linctus through unregulated and potentially illegal websites had increased.

This does not prove that lean use is widespread. It does show that the phenomenon is sufficiently established to have influenced national medicines policy.

The British version may not be the American version

Classic American codeine-and-promethazine cough syrup has not historically been readily available in the same form in the UK. British users may instead mix separately obtained medicines, buy imported products online, use counterfeit bottles or improvise with codeine-containing tablets and syrups.

As a result, something described as lean in Britain might contain:

• codeine linctus;

• promethazine;

• other sedating antihistamines;

• crushed codeine tablets;

• co-codamol or other combination medicines;

• counterfeit or imported opioid syrup;

• substances that the purchaser did not expect.

• 
  

This variability is one of the main risks. Users may believe they are taking a familiar drink with a predictable strength when they are actually consuming an unknown combination of depressant drugs.

Why can it be dangerous?

The most immediate danger is respiratory depression.

Codeine can slow breathing. Promethazine adds further sedation. Larger quantities may cause unconsciousness, respiratory arrest and death. The danger increases substantially when lean is combined with alcohol, benzodiazepines, pregabalin, gabapentin, heroin, methadone or other sedatives.

This is particularly important because lean may be consumed socially as a drink. Users can continue sipping it without clearly knowing how much codeine they have taken. The effects may also build gradually, leading someone to consume more before the full dose has taken effect.

Codeine itself can cause abnormal breathing and respiratory arrest.

There is also a specific risk from combination painkillers. Some UK codeine medicines also contain paracetamol or ibuprofen. Attempting to make lean from these products may expose the user to toxic quantities of the additional medicine. Large doses of paracetamol can cause severe liver injury, while excessive ibuprofen can cause stomach bleeding and kidney damage.

Dependence can develop quietly

Because codeine is a medicine, some people view it as safer than street opioids. This can create a false sense of security.

Regular use can produce:

• increasing tolerance;

• a need to use more to obtain the same effect;

• cravings and preoccupation;

• withdrawal symptoms;

• difficulty sleeping without it;

• anxiety, low mood and irritability;

• continued use despite health, financial or relationship problems.

  
  

The transition into dependence may not look like conventional heroin use. Someone may continue to see themselves as drinking syrup rather than using an opioid. The music, packaging and ritual of preparing the drink can also become part of its appeal.

When use stops, opioid withdrawal may include sweating, yawning, restlessness, stomach cramps, diarrhoea, nausea, muscle pain and disrupted sleep.

Cultural visibility is not the same as prevalence

Lean illustrates a broader challenge in understanding emerging drug trends. A substance can become highly visible culturally without becoming common across the general population.

References in music, online videos and photographs can make a drug appear normal, fashionable or widely used. Some people may display bottles or imitate the imagery without regularly consuming genuine codeine syrup. Others may use it occasionally, while a much smaller group develops serious opioid dependence.

It is therefore sensible to avoid two extremes. Lean should not be presented as a new epidemic without evidence. Equally, it should not be dismissed as an American trend with no relevance to the UK.

A more accurate description is that lean is a culturally visible, poorly measured and potentially dangerous form of pharmaceutical opioid use.

What should practitioners ask?

Workers should avoid assuming that everyone uses the term in the same way. Useful questions include:

• What do you mean when you say lean?

• What products or medicines are being mixed?

• Where did they come from?

• How much is used in one drink?

• How long does one bottle or mixture last?

• Is it combined with alcohol, tablets or other drugs?

• Is the person using it to socialise, sleep, manage distress or avoid withdrawal?

• Have they experienced blackouts, vomiting, blue lips, unusual snoring or difficulty waking?

• 
  

These questions help move the conversation away from the label and towards the actual substances, pattern of use and level of risk.

A balanced conclusion

Lean does not currently appear to be one of the most commonly used drugs in the UK, but precise prevalence data do not exist. It has a clear presence within some youth and online cultures, and concerns about misuse contributed to the decision to make codeine linctus prescription-only.

Its colourful appearance and association with music can disguise a simpler reality: lean is often an unpredictable opioid-and-sedative mixture.

For many people, experimentation may be occasional. For others, tolerance and dependence can develop. In either case, combining codeine with promethazine, alcohol or other depressants can cause a fatal overdose.

The most useful response is neither panic nor dismissal. It is accurate information, careful assessment and a clear recognition that a fashionable-looking drink may contain a powerful opioid.